(5S)-2-[3-[2-(1,1-difluoroethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(difluoromethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-(3-ethynyl-1H-isoindol-5-yl)-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(1-methylcyclopropyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one
C148H149F4N31O8 — CID 158320869
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-2-[3-[2-(1,1-difluoroethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(difluoromethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-(3-ethynyl-1H-isoindol-5-yl)-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(1-methylcyclopropyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one
(5S)-2-[3-[2-(1,1-difluoroethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(difluoromethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-(3-ethynyl-1H-isoindol-5-yl)-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(1-methylcyclopropyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one (PubChem CID 158320869) has the molecular formula C148H149F4N31O8 and a molecular weight of 2566.02 g/mol. Its IUPAC name is (5S)-2-[3-[2-(1,1-difluoroethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(difluoromethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-(3-ethynyl-1H-isoindol-5-yl)-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(1-methylcyclopropyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one.
Molecular Properties
| Compound Name | (5S)-2-[3-[2-(1,1-difluoroethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(difluoromethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-(3-ethynyl-1H-isoindol-5-yl)-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(1-methylcyclopropyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one |
|---|---|
| PubChem CID | 158320869 |
| Molecular Formula | C148H149F4N31O8 |
| Molecular Weight | 2566.02 g/mol |
| Exact Mass | 2564.21 |
| IUPAC Name | (5S)-2-[3-[2-(1,1-difluoroethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(difluoromethyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-(3-ethynyl-1H-isoindol-5-yl)-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one;(5S)-2-[3-[2-(1-methylcyclopropyl)-4-pyridinyl]-1H-isoindol-5-yl]-7-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one |
| SMILES | C#CC1=NCc2ccc(N3CC[C@]4(CCN(CC(=O)N5CC=C(c6ccc(-c7ncn(C)n7)cc6)CC5)C4)C3=O)cc21.Cn1cnc(-c2ccc(C3=CCN(C(=O)CN4CC[C@]5(CCN(c6ccc7c(c6)C(c6ccnc(C(C)(F)F)c6)=NC7)C5=O)C4)CC3)cc2)n1.Cn1cnc(-c2ccc(C3=CCN(C(=O)CN4CC[C@]5(CCN(c6ccc7c(c6)C(c6ccnc(C(F)F)c6)=NC7)C5=O)C4)CC3)cc2)n1.Cn1cnc(-c2ccc(C3=CCN(C(=O)CN4CC[C@]5(CCN(c6ccc7c(c6)C(c6ccnc(C8(C)CC8)c6)=NC7)C5=O)C4)CC3)cc2)n1 |
| InChI | InChI=1S/C40H42N8O2.C38H38F2N8O2.C37H36F2N8O2.C33H33N7O2/c1-39(12-13-39)34-21-30(9-16-41-34)36-33-22-32(8-7-31(33)23-42-36)48-20-15-40(38(48)50)14-19-46(25-40)24-35(49)47-17-10-28(11-18-47)27-3-5-29(6-4-27)37-43-26-45(2)44-37;1-37(39,40)32-19-28(9-14-41-32)34-31-20-30(8-7-29(31)21-42-34)48-18-13-38(36(48)50)12-17-46(23-38)22-33(49)47-15-10-26(11-16-47)25-3-5-27(6-4-25)35-43-24-45(2)44-35;1-44-23-42-35(43-44)26-4-2-24(3-5-26)25-9-14-46(15-10-25)32(48)21-45-16-11-37(22-45)12-17-47(36(37)49)29-7-6-28-20-41-33(30(28)19-29)27-8-13-40-31(18-27)34(38)39;1-3-29-28-18-27(9-8-26(28)19-34-29)40-17-13-33(32(40)42)12-16-38(21-33)20-30(41)39-14-10-24(11-15-39)23-4-6-25(7-5-23)31-35-22-37(2)36-31/h3-10,16,21-22,26H,11-15,17-20,23-25H2,1-2H3;3-10,14,19-20,24H,11-13,15-18,21-23H2,1-2H3;2-9,13,18-19,23,34H,10-12,14-17,20-22H2,1H3;1,4-10,18,22H,11-17,19-21H2,2H3/t40-;38-;37-;33-/m0000/s1 |
| InChIKey | GOVHKFLLPFXRPA-LGQAZGFSSA-N |
| XLogP | 18.18 |
| TPSA | 386.39 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 191 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2566.02 |
| LogP ≤ 5 | 18.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 31 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158320869 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.